Apellis Pharmaceuticals, Inc.

DB:1JK Stock Report

Market Cap: €3.6b

Apellis Pharmaceuticals, Inc. Company Information

Apellis Pharmaceuticals, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Apellis Pharmaceuticals, Inc.
  • Ticker: 1JK
  • Exchange: DB
  • Founded: 2009
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$3.984b
  • Listing Market Cap: US$3.580b
  • Shares Outstanding: 121.77m
  • Website: https://www.apellis.com

Number of Employees

Location

  • Apellis Pharmaceuticals, Inc.
  • 100 Fifth Avenue
  • Waltham
  • Massachusetts
  • 02451
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
APLSNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDNov 2017
1JKDB (Deutsche Boerse AG)YesCommon StockDEEURNov 2017

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/09/24 19:03
End of Day Share Price 2024/09/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.